A significant shift in Canadian drug policy has taken place, as the authorities allow the use of psilocybin hallucinogens for therapeutic applications. Previously, these substances were severely restricted, but a increasing body of research suggests they may offer relief for mental health illnesses like depression. The new policy represents a major